Sequence of pituitary-adrenal cortical hormone responses to low-dose physostigmine administration in young adult women and men

Life Sciences

Volumn 79, Issue 24, 2006, Pages 2260-2268

  Rubin, Robert T ^a   Rhodes, Michael E ^b   Miller, Thomas H ^c   Jakab, Robert L ^d   Czambel, R Kenneth ^d  

^a VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

^b SAINT VINCENT COLLEGE   (United States)

^c UNIVERSITY OF PITTSBURGH   (United States)

^d DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

ACTH; Cholinergic; Cortisol; Physostigmine; Sex difference

Indexed keywords

CORTICOTROPIN; PHYSOSTIGMINE;

ABNORMALLY HIGH SUBSTRATE CONCENTRATION IN BLOOD; ADULT; ARTICLE; BLOOD SAMPLING; CENTRAL NERVOUS SYSTEM; CHOLINERGIC SYSTEM; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIZZINESS; DRUG SAFETY; FEMALE; HORMONE RELEASE; HORMONE RESPONSE; HUMAN; HYPOPHYSIS ADRENAL SYSTEM; MALE; NAUSEA; SEX DIFFERENCE; STATISTICAL SIGNIFICANCE; VOMITING; XEROSTOMIA;

ADRENOCORTICOTROPIC HORMONE; ADULT; AREA UNDER CURVE; ARGININE VASOPRESSIN; CHOLINESTERASE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; HYDROCORTISONE; MALE; PHYSOSTIGMINE; PITUITARY-ADRENAL SYSTEM; REFERENCE VALUES; SEX FACTORS; TIME FACTORS;

EID: 33750514774     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2006.07.023     Document Type: Article

References (58)

1. Aedo A.R., Landgren B.M., and Diczfalusy E. Studies on ovarian and adrenal studies at different phases of the menstrual cycle IV. The effect of dexamethasone suppression and subsequent ACTH stimulation at different phases of the menstrual cycle and following the administration of 150 mg of depot-medroxy-progrsterone acetate (DMPA). Contraception 24 (1981) 543-558
2. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. Fourth ed. (1994), American Psychiatric Press, Washington, DC
3. Antoni F.A. Vasopressinergic control of pituitary adrenocorticotropin secretion comes of age. Frontiers in Neuroendocrinology 14 (1993) 76-122
4. Assenmacher I., Szafarcyzk A., Alonso G., Ixart G., and Barbanel G. Physiology of neural pathways affecting CRH secretion. Annals of the New York Academy of Sciences 512 (1987) 149-161
5. Baldino Jr. F., O'Kane T.M., and Fitzpatrick-McElligott S. Coordinate hormonal and synaptic regulation of vasopressin messenger RNA. Science 241 (1988) 978-981
6. Calogero A.E. Neurotransmitter regulation of the hypothalamic corticotropin-releasing hormone neuron. Annals of the New York Academy of Sciences 771 (1995) 31-40
7. Carroll B.J., Greden J.F., Haskett R., Feinberg M., Albala A.A., Martin F.I., Rubin R.T., Heath B., Sharp P.T., McLeod W.L., and McLeod M.F. Neurotransmitter studies of neuroendocrine pathology in depression. Acta Psychiatrica Scandinavica. Supplementum 280 (1980) 183-199
8. Cirino M., and Renaud L.P. Influence of lateral septum and amygdala stimulation on the excitability of hypothalamic supraoptic neurons. An electrophysiological study in the rat. Brain Research 326 (1985) 357-361
9. Coiro V., Volpi R., Capretti L., Colla R., Caffarri G., Vescovi P.P., and Chiodera P. Dopaminergic and cholinergic control of arginine-vasopressin secretion in type I diabetic men. European Journal of Clinical Investigation 25 (1995) 412-417
10. Darlington R.B., and Hayes A.F. Combining independent p values: extensions of the Stouffer and binomial methods. Psychological Methods 5 (2000) 496-515
11. Davis B.M., Brown G.M., Miller M., Friesen H.G., Kastin A.J., and Davis K.L. Effects of cholinergic stimulus on pituitary hormone release. Psychoneuroendocrinology 7 (1982) 347-354
12. De Vries G.J., and Panzica G.C. Sexual differentiation of central vasopressin and vasotocin systems in vertebrates: different mechanisms, similar endpoints. Neuroscience 138 (2006) 947-955
13. De Vries G.J., Wang Z., Bullock N.A., and Numan S. Sex differences in the effects of testosterone and its metabolites on vasopressin messenger RNA levels in the bed nucleus of the stria terminalis of rats. Journal of Neuroscience 14 (1994) 1789-1794
14. De Vries G.J., Al-Shamma H.A., and Zhou L. The sexually dimorphic vasopressin innervation of the brain as a model for steroid modulation of neuropeptide transmission. Annals of the New York Academy of Sciences 743 (1994) 95-120
15. Doerr P., and Berger M. Physostigmine-induced escape from dexamethasone suppression in normal adults. Biological Psychiatry 18 (1983) 261-268
16. Fernandes K.B., Tavares R.F., and Correa F.M. The lateral septal area is involved in the pressor pathway activated by microinjection of norepinephrine into the rat brain cingulate cortex. Neuropharmacology 49 (2005) 564-571
17. Fibiger H.C., Damsma G., and Day J.C. Behavioral pharmacology and biochemistry of central cholinergic neurotransmission. In: Napier T.C., Kalivas P.W., and Hanin I. (Eds). The Basal Forebrain (1991), Plenum Press, New York 399-414
18. First M.B., Spitzer R.L., Gibbon M., and Williams J.B.W. Structured Clinical Interview for DSM-IV Axis I Disorders-non-patient Edition (SCID-I/NP, version 2.0) (1996), Biometrics Research Department, New York State Psychiatric Institute, New York, NY
19. Fliers E., Guldenaar S.E.F., v.d. Wal N., and Swaab D.F. Extrahypothalamic vasopressin and oxytocin in the human brain: presence of vasopressin cells in the bed nucleus of the stria terminalis. Brain Research 375 (1986) 363-367
20. Florkowski C.M., Crozier I.G., Nightingale S., Evans M.J., Ellis M.J., Joyce P., and Donald R.A. Plasma cortisol, PRL, ACTH, AVP, and corticotrophin releasing hormone responses to direct current cardioversion and electroconvulsive therapy. Clinical Endocrinology 44 (1996) 163-168
21. Freeman E., Touze R., Grossman A., Besser M., and Ross R. Pyridostigmine, an acetylcholinesterase inhibitor, stimulates growth hormone release, but has no effect on basal thyrotrophin or adrenocorticotrophin levels, or the thyrotrophin response to thyrotrophin-releasing hormone. Journal of Neuroendocrinology 2 (1990) 429-432
22. Genç S., Gürdöl F., Güvenç S., and Kargi{dotless} Y. Variations in serum cholinesterase activity in different age and sex groups. European Journal of Clinical Chemistry and Clinical Biochemistry 35 (1997) 239-240
23. Gregg C.M. The compartmentalized hypothalamo-neurohypophysial system: evidence for a neurohypophysial action of acetylcholine on vasopressin release. Neuroendocrinology 40 (1985) 423-429
24. Hamilton M. Development of a rating scale for primary depressive illness. British Journal of Social and Clinical Psychology 6 (1967) 278-296
25. Herman J.P., Prewitt C.M., and Cullinan W.E. Neuronal circuit regulation of the hypothalamo-pituitary-adrenocortical stress axis. Critical Reviews in Neurobiology 10 (1996) 371-394
26. Ishunina T.A., and Swaab D.F. Vasopressin and oxytocin neurons of the human supraoptic and paraventricular nucleus: size changes in relation to age and sex. Journal of Clinical Endocrinology and Metabolism 84 (1999) 4637-4644
27. Janowsky D.S., Risch S.C., Kennedy B., Ziegler M., and Huey L. Central muscarinic effects of physostigmine on mood, cardiovascular function, pituitary and adrenal neuroendocrine release. Psychopharmacology 89 (1986) 150-154
28. Karanth S., Lyson K., and McCann S.M. Effects of cholinergic agonists and antagonists on interleukin-2-induced corticotropin-releasing hormone release from the mediobasal hypothalamus. Neuroimmunomodulation 6 (1999) 168-174
29. Krieg J.-C., Bossert S., Pirke K.-M., von Zerssen D., and Berger M. The influence of the muscarinic agonist RS 86 on the cortisol system. Biological Psychiatry 22 (1987) 573-582
30. Lewis D.A., Sherman B.M., and Kathol R.G. Analysis of the specificity of physostigmine stimulation of adrenocorticotropin in man. Journal of Clinical Endocrinology and Metabolism 58 (1984) 570-573
31. Michels K.M., Meeker R.B., and Hayward J.N. Muscarinic cholinergic control of vasopressin secretion from the acute hypothalamoneurohypophysial explant. Neuroendocrinology 54 (1991) 219-226
32. Nurnberger Jr. J.I., Jimerson D.C., Simmons-Alling S., Tamminga C., Nadi N.S., Lawrence D., Sitaram N., Gillin J.C., and Gershon E.S. Behavioral, physiological, and neuroendocrine responses to arecoline in normal twins and "well state" bipolar patients. Psychiatry Research 9 (1983) 191-200
33. Nussey S.S., Page S.R., Peterson D.B., Byrne J., Crosby S.R., White A., Ang V.T.Y., Jackson R., and Jenkins J.S. Corticotrophin releasing hormone (CRH1-41) stimulates the secretion of adrenocorticotrophin, vasopressin and oxytocin but not adrenocorticotrophin precursors: evidence from petrosal sinus sampling in man. Clinical Endocrinology 34 (1991) 51-56
34. Ohmori N., Itoi K., Tozawa F., Sakai Y., Sakai K., Horiba N., Demura H., and Suda T. Effect of acetylcholine on corticotropin-releasing factor gene expression in the hypothalamic paraventricular nucleus of conscious rats. Endocrinology 136 (1995) 4858-4863
35. Okuda H., Shioda S., Nakai Y., Nakayama H., Okamoto M., and Nakashima T. The presence of corticotropin-releasing factor-like immunoreactive synaptic vesicles in axon terminals with nicotinic acetylcholine receptor-like immunoreactivity in the median eminence of the rat. Neuroscience Letters 161 (1993) 183-186
36. Poulain D.A., Lebrun C.J., and Vincent J.D. Electrophysiological evidence for connections between septal neurones and the supraoptic nucleus of the hypothalamus of the rat. Experimental Brain Research 42 (1981) 260-268
37. Rhodes M.E., and Rubin R.T. Functional sex differences ('sexual diergism') of central nervous system cholinergic systems, vasopressin, and hypothalamic-pituitary-adrenal axis activity in mammals: a selective review. Brain Research Reviews 30 (1999) 135-152
38. Rhodes M.E., O'Toole S.M., Wright S.L., Czambel R.K., and Rubin R.T. Sexual diergism in rat hypothalamic-pituitary-adrenal axis responses to cholinergic stimulation and antagonism. Brain Research Bulletin 54 (2001) 101-113
39. Rhodes M.E., Balestreire E.M., Czambel R.K., and Rubin R.T. Estrous cycle influences on sexual diergism of HPA axis responses to cholinergic stimulation in rats. Brain Research Bulletin 59 (2002) 217-225
40. Rhodes M.E., Billings T.E., Czambel R.K., and Rubin R.T. Pituitary-adrenal responses to cholinergic stimulation in male and female M2 muscarinic receptor knockout mice. Journal of Neuroendocrinology 17 (2005) 817-826
41. Rittmaster R.S., Cutler G.B., Gold P.W., Brandon D.D., Tomai T., Loriaux D.L., and Chrousos G.P. The relationship of saline-induced changes in vasopressin secretion to basal and corticotropin-releasing hormone-stimulated adrenocorticotropin and cortisol secretion in man. Journal of Clinical Endocrinology and Metabolism 64 (1987) 371-376
42. Rivier C., Smith M., and Vale W. Regulation of adrenocorticotropic hormone (ACTH) secretion by corticotropin releasing factor (CRF). In: De Souza E.B., and Nemeroff C.B. (Eds). Corticotropin Releasing Factor: Basic and Clinical Studies of a Neuropeptide (1990), CRC Press, Boca Raton 175-203
43. Rossor M.N., Iversen L.L., Hawthorn J., Ang V.T.Y., and Jenkins J.S. Extrahypothalamic vasopressin in human brain. Brain Research 214 (1981) 349-355
44. Rubin R.T., Poland R.E., Lesser I.M., Winston R.A., and Blodgett A.L.N. Neuroendocrine aspects of primary endogenous depression I. Cortisol secretory dynamics in patients and matched control subjects. Archives of General Psychiatry 44 (1987) 329-336
45. Rubin R.T., Phillips J.J., Sadow T.F., and McCracken J.T. Adrenal gland volume in major depression. Increase during the depressive episode and decrease with successful treatment. Archives of General Psychiatry 52 (1995) 213-218
46. Rubin R.T., Sekula L.K., O'Toole S., Rhodes M.E., and Czambel R.K. Pituitary-adrenal cortical responses to low-dose physostigmine and arginine vasopressin administration in normal women and men. Neuropsychopharmacology 20 (1999) 434-446
47. Sukhov R.R., Walker L.C., Rance N.E., Price D.L., and Young III W.S. Vasopressin and oxytocin gene expression in the human hypothalamus. Journal of Comparative Neurology 337 (1993) 295-306
48. Swaab D.F. Development of the human hypothalamus. Neurochemistry Research 20 (1995) 509-519
49. Swaab D.F., Gooren L.J., and Hofman M.A. Brain research, gender and sexual orientation. Journal of Homosexuality 28 (1995) 283-301
50. Swaab D.F., Chung W.C.J., Kruijver F.P.M., Hofman M.A., and Ishunina T.A. Structural and functional sex differences in the human hypothalamus. Hormones and Behavior 40 (2001) 93-98
51. Thompson L.M., and Rubin R.T. Neuroendocrine aspects of primary endogenous depression XIII. Influence of race on differences in hypothalamo-pituitary-adrenal and pituitary-thyroid function between patients and matched controls. Biological Psychiatry 34 (1993) 893-895
52. Thompson L.M., Rubin R.T., and McCracken J.T. Neuroendocrine aspects of primary endogenous depression XII. Receiver operating characteristic and kappa analyses of serum and urine cortisol measures in patients and matched controls. Psychoneuroendocrinology 17 (1992) 507-515
53. Tsagarakis S., and Grossman A. Central neuroregulation of hypothalamic corticotropin-releasing hormone (CRH-41) secretion. Journal of Endocrinological Investigation 13 (1990) 765-775
54. Tuomisto J., and Männistö P. Neurotransmitter regulation of anterior pituitary hormones. Pharmacological Reviews 37 (1985) 249-332
55. Viau V., and Meaney M.J. The inhibitory effect of testosterone on hypothalamic-pituitary-adrenal responses to stress is mediated by the medial preoptic area. Journal of Neuroscience 16 (1996) 1866-1876
56. Wainer B.H., Steininger T.L., Roback J.D., Burke-Watson M.A., Mufson E.J., and Kordower J. Ascending cholinergic pathways: functional organization and implications for disease models. Progress in Brain Research 98 (1993) 9-30
57. Wei R., Phillips T.M., and Sternberg E.M. Specific up-regulation of CRH or AVP secretion by acetylcholine or lipopolysaccharide in inflammatory susceptible Lewis rat fetal hypothalamic cells. Journal of Neuroimmunology 131 (2002) 31-40
58. Whitnall M.H. Regulation of the hypothalamic corticotropin-releasing hormone neurosecretory system. Progress in Neurobiology 40 (1993) 573-629